Merck & Co Inc logo

Merck & Co Inc

UKEX:MRK (USA)  
₴ 3812.00 (0%) Sep 22
On watch
P/E:
87.16
P/B:
6.98
Market Cap:
₴ 10.05T ($ 273.02B)
Enterprise V:
₴ 11.18T ($ 303.91B)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap ₴:
10.05T
Market Cap $:
273.02B
PE Ratio:
87.16
Avg Vol (2M):
-
Enterprise Value ₴:
11.18T
Enterprise Value $:
303.91B
PB Ratio:
6.98

Business Description

Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 0.17
Equity-to-Asset 0.37
Debt-to-Equity 0.95
Debt-to-EBITDA 3.64
Interest Coverage 6.4
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.03
Distress
Grey
Safe
Beneish M-Score -2.94
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.28
Quick Ratio 1.03
Cash Ratio 0.27
Days Inventory 133.6
Days Sales Outstanding 62.62
Days Payable 84.46

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Dividend Growth Rate 7.4
Shareholder Yield % 2.47

Financials (Next Earnings Date:2023-10-27 Est.)

UKEX:MRK's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Merck & Co Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ₴) 2,153,332.456
EPS (TTM) (₴) 45.053
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR (₴) 0
20-Day SMA (₴) 3812
12-1 Month Momentum % 0
52-Week Range (₴) 3812 - 3812
Shares Outstanding (Mil) 2,537.52

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Merck & Co Inc Filings

Filing Date Document Date Form
No Filing Data

Merck & Co Inc Stock Events

Event Date Price(₴)
No Event Data

Merck & Co Inc Frequently Asked Questions

What is Merck & Co Inc(UKEX:MRK)'s stock price today?
The current price of UKEX:MRK is ₴3812.00. The 52 week high of UKEX:MRK is ₴3812.00 and 52 week low is ₴3812.00.
When is next earnings date of Merck & Co Inc(UKEX:MRK)?
The next earnings date of Merck & Co Inc(UKEX:MRK) is 2023-10-27 Est..
Does Merck & Co Inc(UKEX:MRK) pay dividends? If so, how much?
Merck & Co Inc(UKEX:MRK) does not pay dividend.

Press Release

Subject Date
No Press Release